Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Patent 11767320 was granted and assigned to Incyte on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Incyte
Incyte
Date Filed
October 1, 2021
Date of Patent
September 26, 2023
Patent Applicant
Incyte
Incyte
Patent Application Number
17449696
Patent Citations
‌
US Patent 7973163 Fused quinoline derivative and use thereof
‌
US Patent 7592453 Fused quinoline derivative and use thereof
‌
US Patent 7897609 Aryl substituted imidazonaphthyridines
‌
US Patent 7943770 Fused quinoline derivative and use thereof
‌
US Patent 9550776 Pyridinylpyrazoloquinoline compounds
‌
US Patent 9573947 Salt of pyrazoloquinoline derivative, and crystal thereof
‌
US Patent 9694006 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
‌
US Patent 9771327 Compounds and methods for the treatment of cystic fibrosis
‌
US Patent 9873683 P2X4 receptor antagonist
‌
US Patent 9873694 Imidazole quinoline-based immune system modulators
•••
Patent Inventor Names
Wenqing Yao
Taisheng Huang
Xiaozhao Wang
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11767320
Patent Primary Examiner
‌
John M Mauro
CPC Code
‌
C07D 471/04
‌
A61P 35/00
‌
A61P 29/00
‌
A61P 37/00
‌
C07B 2200/05

Find more entities like US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.